Barbara E. Lippok

644 total citations
13 papers, 500 citations indexed

About

Barbara E. Lippok is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Barbara E. Lippok has authored 13 papers receiving a total of 500 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 6 papers in Molecular Biology and 6 papers in Immunology. Recurrent topics in Barbara E. Lippok's work include PARP inhibition in cancer therapy (9 papers), Toxin Mechanisms and Immunotoxins (6 papers) and Cytokine Signaling Pathways and Interactions (4 papers). Barbara E. Lippok is often cited by papers focused on PARP inhibition in cancer therapy (9 papers), Toxin Mechanisms and Immunotoxins (6 papers) and Cytokine Signaling Pathways and Interactions (4 papers). Barbara E. Lippok collaborates with scholars based in Germany, Finland and Italy. Barbara E. Lippok's co-authors include Bernhard Lüscher, Peter C. Heinrich, Heike M. Hermanns, Simone Radtke, Patricia Verheugd, Karla L. H. Feijs, Sarah Krieg, Stefan Pflanz, Mareike Bütepage and Giulia Rossetti and has published in prestigious journals such as Journal of Biological Chemistry, Scientific Reports and Journal of Cell Science.

In The Last Decade

Barbara E. Lippok

12 papers receiving 492 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barbara E. Lippok Germany 11 321 220 161 54 52 13 500
Éric Winstall Canada 13 203 0.6× 124 0.6× 442 2.7× 41 0.8× 47 0.9× 15 626
Ying Miao China 14 224 0.7× 190 0.9× 293 1.8× 37 0.7× 17 0.3× 39 594
Frédéric R. Sallmann Canada 6 214 0.7× 79 0.4× 299 1.9× 28 0.5× 18 0.3× 8 477
Asako Itaya Japan 13 374 1.2× 127 0.6× 430 2.7× 45 0.8× 48 0.9× 20 593
Huiting Wei China 8 211 0.7× 148 0.7× 330 2.0× 16 0.3× 11 0.2× 12 524
Ronald E. Esser United States 13 105 0.3× 125 0.6× 221 1.4× 16 0.3× 13 0.3× 14 634
Byunghee Koh United States 13 81 0.3× 314 1.4× 153 1.0× 9 0.2× 6 0.1× 20 519
Ian M. Cartwright United States 13 42 0.1× 70 0.3× 196 1.2× 24 0.4× 8 0.2× 31 371
Mauro Gaya United Kingdom 11 70 0.2× 489 2.2× 180 1.1× 46 0.9× 17 0.3× 15 727
Travis Lear United States 17 81 0.3× 215 1.0× 476 3.0× 45 0.8× 9 0.2× 29 722

Countries citing papers authored by Barbara E. Lippok

Since Specialization
Citations

This map shows the geographic impact of Barbara E. Lippok's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara E. Lippok with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara E. Lippok more than expected).

Fields of papers citing papers by Barbara E. Lippok

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara E. Lippok. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara E. Lippok. The network helps show where Barbara E. Lippok may publish in the future.

Co-authorship network of co-authors of Barbara E. Lippok

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara E. Lippok. A scholar is included among the top collaborators of Barbara E. Lippok based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara E. Lippok. Barbara E. Lippok is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Lippok, Barbara E., Mirko M. Maksimainen, Giuseppe Manfroni, et al.. (2025). Optimization of 2,3-dihydrophthalazine-1,4-dione PARP inhibitor scaffold for nanomolar potency and specificity towards human PARP10. European Journal of Medicinal Chemistry. 300. 118111–118111.
2.
Krieg, Sarah, Fabian Pott, Mareike Bütepage, et al.. (2023). Mono-ADP-ribosylation by PARP10 inhibits Chikungunya virus nsP2 proteolytic activity and viral replication. Cellular and Molecular Life Sciences. 80(3). 72–72. 18 indexed citations
3.
Maksimainen, Mirko M., Serena Massari, Barbara E. Lippok, et al.. (2023). [1,2,4]Triazolo[3,4- b ]benzothiazole Scaffold as Versatile Nicotinamide Mimic Allowing Nanomolar Inhibition of Different PARP Enzymes. Journal of Medicinal Chemistry. 66(2). 1301–1320. 15 indexed citations
4.
Maksimainen, Mirko M., Serena Massari, Barbara E. Lippok, et al.. (2022). Potent 2,3-dihydrophthalazine-1,4-dione derivatives as dual inhibitors for mono-ADP-ribosyltransferases PARP10 and PARP15. European Journal of Medicinal Chemistry. 237. 114362–114362. 7 indexed citations
5.
Korn, Patricia, Arno Claßen, Mirko M. Maksimainen, et al.. (2021). Evaluation of 3‐ and 4‐Phenoxybenzamides as Selective Inhibitors of the Mono‐ADP‐Ribosyltransferase PARP10. ChemistryOpen. 10(10). 939–948. 10 indexed citations
6.
Žaja, Roko, et al.. (2020). Comparative analysis of MACROD1, MACROD2 and TARG1 expression, localisation and interactome. Scientific Reports. 10(1). 8286–8286. 30 indexed citations
7.
Eckei, Laura, Sarah Krieg, Mareike Bütepage, et al.. (2017). The conserved macrodomains of the non-structural proteins of Chikungunya virus and other pathogenic positive strand RNA viruses function as mono-ADP-ribosylhydrolases. Scientific Reports. 7(1). 41746–41746. 107 indexed citations
8.
Hartkamp, Jörg, Patricia Verheugd, Alexandra Forst, et al.. (2013). Caspase‐dependent cleavage of the mono‐ADP‐ribosyltransferase ARTD10 interferes with its pro‐apoptotic function. FEBS Journal. 280(5). 1330–1343. 49 indexed citations
9.
Kleine, H. O., Andreas Herrmann, Trond Lamark, et al.. (2012). Dynamic subcellular localization of the mono-ADP-ribosyltransferase ARTD10 and interaction with the ubiquitin receptor p62. Cell Communication and Signaling. 10(1). 28–28. 55 indexed citations
10.
Radtke, Simone, Stefan Wüller, Xiang‐Ping Yang, et al.. (2010). Cross-regulation of cytokine signalling: pro-inflammatory cytokines restrict IL-6 signalling through receptor internalisation and degradation. Journal of Cell Science. 123(6). 947–959. 81 indexed citations
11.
Evers, Christina, Barbara E. Lippok, Rudolf Volkmer, et al.. (2008). Box 2 Region of the Oncostatin M Receptor Determines Specificity for Recruitment of Janus Kinases and STAT5 Activation. Journal of Biological Chemistry. 283(28). 19465–19477. 30 indexed citations
12.
13.
Radtke, Simone, et al.. (2004). Characterization of the Signaling Capacities of the Novel gp130-like Cytokine Receptor. Journal of Biological Chemistry. 279(34). 36112–36120. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Éric Winstall Breakdown of academic impact, for papers by Ying Miao Breakdown of academic impact, for papers by Frédéric R. Sallmann Breakdown of academic impact, for papers by Asako Itaya Breakdown of academic impact, for papers by Huiting Wei Breakdown of academic impact, for papers by Ronald E. Esser Breakdown of academic impact, for papers by Byunghee Koh Breakdown of academic impact, for papers by Ian M. Cartwright Breakdown of academic impact, for papers by Mauro Gaya Breakdown of academic impact, for papers by Travis Lear
Rankless by CCL
2026